Skip to main content
Equibles

James R. Meyers

Board Member

CytomX Therapeutics, Inc. (CTMX)

Board Member

Vera Therapeutics, Inc. (VERA)

Equibles does not estimate personal net worth.

Get an email with a short summary when CytomX Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get CTMX alerts

About James R. Meyers

James R. Meyers is recorded as Board Member at CytomX Therapeutics, Inc. (CTMX) and Board Member at Vera Therapeutics, Inc. (VERA) since January 1, 2025. The newest filing on record that lists James R. Meyers as Board Member at CytomX Therapeutics, Inc. (CTMX) is dated April 30, 2026. The newest filing on record that lists James R. Meyers as Board Member at Vera Therapeutics, Inc. (VERA) is dated April 9, 2026. Vera Therapeutics, Inc. reported in an 8-K filed November 26, 2025 that James R. Meyers was appointed Class II Director, effective November 25, 2025. CytomX Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Vera Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CytomX Therapeutics, Inc. includes Sean McCarthy (CEO and Board Member), Chris Ogden (CFO and Chief Accounting Officer), Lloyd A. Rowland (General Counsel) and 7 others.

“On November 25, 2025, the board of directors (the "Board") of Vera Therapeutics, Inc. (the "Company") appointed James R. Meyers to the Board, effective immediately.”
Vera Therapeutics, Inc. Form 8-K, filed November 26, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at CytomX Therapeutics, Inc.

Leadership on record at Vera Therapeutics, Inc.

Recent activity